Cancer research demands precision to resolve tumor heterogeneity, identify rare malignant and immune cell populations, and characterize cell-state–specific transcriptional programs that drive disease progression and therapeutic response. Parse Biosciences Evercode™ technology empowers researchers to profile complex tumor ecosystems at single cell resolution without specialized hardware or rigid workflows.

Join our online info session on January 15 at 8:00 AM Pacific to learn how Parse Biosciences’ combinatorial barcoding enables cancer research, what the grant includes, and how to apply.